about
Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET studyChromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics StudyElusive roles for reactive astrocytes in neurodegenerative diseasesSolvents and Parkinson disease: a systematic review of toxicological and epidemiological evidenceEarly presymptomatic and long-term changes of rest activity cycles and cognitive behavior in a MPTP-monkey model of Parkinson's diseasePharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genesTrichloroethylene and parkinsonism: a human and experimental observationAntiarrhythmics cure brain arrhythmia: The imperativeness of subthalamic ERG K+ channels in parkinsonian discharges.Clinical applications of mesenchymal stem cells in chronic diseases.Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease.Age-related myelin dynamics revealed by increased oligodendrogenesis and short internodesA microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools.Human nerual stem cells for brain repairAcupuncture Stimulation at GB34 Restores MPTP-Induced Neurogenesis Impairment in the Subventricular Zone of Mice.Pharmacotherapy for advanced Parkinson's disease.Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease.Deep brain stimulation: technology at the cutting edgeParkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's diseaseEnhanced efficacy of human brain-derived neural stem cells by transplantation of cell aggregates in a rat model of Parkinson's disease.Expression of mutant alpha-synuclein modulates microglial phenotype in vitroAxial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulationEffects of deep brain stimulation and levodopa on postural sway in Parkinson's diseaseStimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow upBilateral subthalamic nucleus stimulation improves balance control in Parkinson's diseaseAge- and duration-dependent effects of MPTP on cortical serotonin systemsRecent progress of imaging agents for Parkinson's disease.Mitochondrial nutrition as a strategy for neuroprotection in Parkinson's disease—research focus in the department of alternative medicine and experimental therapeutics at Hokuriku UniversitySPECT molecular imaging in Parkinson's diseaseInhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease ModelAlzheimer's disease: A hypothesis on pathogenesis.The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's diseaseHistory of Neural Stem Cell Research and Its Clinical Application.Genotype and age at Parkinson disease diagnosis.Moieties in antidiabetic drugs as a target of insulin receptors in association with common neurological disorders.Role of activity-dependent mechanisms in the control of dopaminergic neuron survival.Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.
P2860
Q21134536-78989B42-F3E4-401D-BAF3-34A1ACE4D43CQ24539105-EB329B25-C02D-4213-9EEC-AF332AC0167EQ26797399-49F1D934-814C-4D4A-B37D-3125110082FCQ26852462-7E464008-EFF5-45D1-B6C8-15CF0305AC35Q27322880-2A09E295-C3E7-4F0F-93E7-1AAC35B4577DQ28088705-AD4D8E74-CE51-426C-B611-97982CFDA8DAQ28371417-2042A348-CC33-4645-A912-9C69E62D8289Q29994716-1441FF15-C268-4692-AFAD-E535234698E1Q30437823-DF114A7D-0A1D-4560-BCD0-60ED509EBF31Q30457611-B505BED8-5B76-4AF1-9612-471C45648228Q30471289-48CB48F4-9513-4C6D-ACCF-B491E4815F84Q30488519-31F8A763-4912-486F-89C7-0B370481E37EQ33219784-DA8EBA2C-AEC7-40A3-829F-90CFFF52C1C6Q33614725-87242C3E-B569-4C53-A1A0-8293CCF6C283Q33737604-AF70AAA4-E996-42DA-92E5-17E1948DEC00Q33821336-C6E96778-EC20-46D5-A089-E0D79406BC21Q33826463-C43F59FD-980C-420C-9040-8E1471F483F5Q34508149-9D0D0094-5EA9-4470-B593-82BC9BD535BDQ34522327-63E4C43D-6606-4E90-BFBC-F7C5ED4828BEQ34587764-91E611BF-3E49-4BF9-8E2D-6E769B5EF949Q34594653-93C5BF9D-C141-42FC-9C01-A635C460219CQ34682391-9B75DCDD-98DD-46BD-AF9B-A9A50C61EA7AQ34749827-A62FF639-DBF0-4C42-A955-BD662A16E971Q35014520-EF2486FE-C2A4-4180-96E5-648DFB3E9472Q35456828-22D04E1A-5525-45BA-829B-33078A9055B9Q35469220-3F8A9FE1-0EF6-4D25-A27A-A1C301873C3AQ35485523-A9820B8C-568E-4042-995E-1A5ADCB2FE7FQ35488203-E4D00157-1DF4-40BD-B3C4-82D85593E3F3Q35534830-27429C8B-1922-4BAA-A65E-8DAE78F8C52BQ35595426-4AADA3E4-42BF-4F2E-AF4A-C8B639023397Q35809081-B871EDD1-FD6F-4CDF-8237-91EB03A5FF22Q35875725-6258D44A-2C02-4383-BA21-6169BB4F57FCQ36237308-E1D80AD5-189B-47BD-B868-DB57B48A0741Q36271097-C876416F-1820-4816-BC20-9A2E22B20D9AQ36626366-FFDEEB45-40EE-493C-9FF0-96CEFD20C6E1Q36685619-E09C5EA4-34B2-4040-AF11-0ED7A45F2D62Q36729049-2E57A8BA-6E60-4E3D-9C56-4E77AD825C4AQ36742174-3BE27C1B-1CD1-412F-8673-13ED2D2CAD0AQ36777897-97BED67A-B884-4BAF-A6E4-B49A48FD6752Q36897560-42683DEA-9834-46B8-8CF0-0C883C8340FF
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Parkinson's disease: pathophysiology.
@ast
Parkinson's disease: pathophysiology.
@en
type
label
Parkinson's disease: pathophysiology.
@ast
Parkinson's disease: pathophysiology.
@en
prefLabel
Parkinson's disease: pathophysiology.
@ast
Parkinson's disease: pathophysiology.
@en
P1433
P1476
Parkinson's disease: pathophysiology.
@en
P304
P356
10.1016/0140-6736(91)92989-F
P407
P50
P577
1991-06-01T00:00:00Z